Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
Imatinib mesylate
48
CHF
CHF 48.00
In stock
SYN-1046-M0011 mgCHF 48.00
SYN-1046-M0055 mgCHF 66.00
SYN-1046-M01010 mgCHF 78.00
SYN-1046-M05050 mgCHF 132.00
SYN-1046-M100100 mgCHF 174.00

Product Details | |
---|---|
Synonyms | CGP-54148; ST-1571 |
Product Type | Chemical |
Properties | |
Formula | C29H31N7O . CH3SO3H |
MW | 493.6 . 96.1 |
CAS | 220127-57-1 |
Purity Chemicals | ≥95% |
Appearance | Solid. |
Solubility | Soluble in DMSO or ethanol. |
Declaration | Manufactured by SynKinase. |
Other Product Data |
Target: Abl - BCR | Kinase Group: PTK | Substrate: Tyrosine Click here for Original Manufacturer Product Datasheet Our product description may differ slightly from the original manufacturers product datasheet. |
InChi Key | YLMAHDNUQAMNNX-UHFFFAOYSA-N |
Shipping and Handling | |
Shipping | AMBIENT |
Short Term Storage | +4°C |
Long Term Storage | -20°C |
Use/Stability | Stable for at least 2 years after receipt when stored at -20°C. |
Documents | |
MSDS |
![]() |
Product Specification Sheet | |
Datasheet |
![]() |
Imatinib is a multi-target inhibitor of v-Abl, c-Kit and PDGFR with IC(50) values of 0.6µM, 0.1µM and 0.1µM, respectively.
Product References
- Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells: B.J. Druker, et al.; Nat. Med. 2, 561 (1996)